Physician

Alejandro Garcia, M.D.

According to 2025 Medicare claims, Alejandro Garcia, M.D. (NPI: 1164666483) practices hematology/oncology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is SOUTHEAST PHYSICIAN NETWORK, P.C. (NPI: 1598090839; TIN: 27-0996600) and primary practice location at 35406-2209. Garcia is affiliated with the Main Street Rural Health Dogwood ACO LLC (ACO ID: A5421), participating under the MSSP model.

Garcia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 97,514 HCPCS/CPT codes, and received $1,017,930 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,978 prescription claims across 303 beneficiaries totaling $8,510,604 in drug costs, led by Xtandi (Enzalutamide). DME data shows 24 claims. Open Payments data shows 65 records totaling $1,331. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,613,398 to $1,017,930. Similarly, Part D prescription costs have moved sharply higher in recent years, from $462,636 to $8,510,604. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	688	125,736	$1,613,398
2016	719	61,059	$917,733
2017	269	1,139	$70,649
2018	290	1,174	$61,431
2019	339	1,333	$80,890
2020	352	5,487	$77,138
2021	182	63,355	$665,954
2022	202	70,835	$941,870
2023	217	78,223	$832,195
2024	276	97,514	$1,017,930

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	716	$462,636
2016	162	534	$318,218
2017	109	552	$409,940
2018	149	766	$1,143,090
2019	174	1,014	$2,020,469
2020	174	985	$2,136,711
2021	209	1,268	$2,610,348
2022	210	1,454	$3,823,973
2023	240	1,529	$5,735,586
2024	303	1,978	$8,510,604

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	51	$23,264
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$41,033

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	68	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	93	169	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	168	291	$59
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	49	188	$45
96372	Injection of drug or substance under skin or into muscle	52	301	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	81	2,430	$1,110,494
Erleada	Apalutamide	44	1,320	$583,493
Imbruvica	Ibrutinib	40	1,144	$489,074
Keytruda	Pembrolizumab	43	903	$475,059
Lenalidomide	Lenalidomide	29	735	$374,362

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$37,078
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$1,331	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandro Garcia, M.D.?

Tedicare shows public-source Medicare data for Alejandro Garcia, M.D. (NPI 1164666483), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandro Garcia, M.D. have ACO affiliation data?

Alejandro Garcia, M.D. is shown with ACO affiliation data for Main Street Rural Health Dogwood ACO LLC (MSSP, ACO ID A5421).

What billing organization is linked to Alejandro Garcia, M.D.?

Alejandro Garcia, M.D. is linked to SOUTHEAST PHYSICIAN NETWORK, P.C. (billing NPI 1598090839) in the available physician profile data.

Does Alejandro Garcia, M.D. have Open Payments data?

Alejandro Garcia, M.D. has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.